A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy
Clinical trial NCT02310763 · TERMINATED
Trial details
- NCT number
- NCT02310763
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-24
- Primary completion
- 2018-04-30
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.